Whereas CD133+ ovarian CSCs have exhibited tumor initiation, self-renewal, and chemoresistance capacity, not all ovarian cancer cell lines express CD133, and a few recent studies reveal no established association between CSCs and CD133[45,46]. The gene discussed is PROM1; the disease is ovarian carcinoma.